GemVax & KAEL Co (XKRX:082270) Interest Expense : ₩-3,161 Mil (TTM As of Dec. 2024)

View and export this data going back to 2005. Start your Free Trial

What is GemVax & KAEL Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. GemVax & KAEL Co's interest expense for the three months ended in Dec. 2024 was ₩ -1,202 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-3,161 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. GemVax & KAEL Co's Operating Income for the three months ended in Dec. 2024 was ₩ -33,462 Mil. GemVax & KAEL Co's Interest Expense for the three months ended in Dec. 2024 was ₩ -1,202 Mil. GemVax & KAEL Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

GemVax & KAEL Co Interest Expense Historical Data

The historical data trend for GemVax & KAEL Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GemVax & KAEL Co Interest Expense Chart

GemVax & KAEL Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-1,229.68

-404.96

-445.31

-462.86

-3,161.18

GemVax & KAEL Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Interest Expense	Get a 7-Day Free Trial															-135.43	-231.89	-718.92	-1,008.39	-1,201.99

GemVax & KAEL Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-3,161 Mil.

GemVax & KAEL Co (XKRX:082270) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

GemVax & KAEL Co's Interest Expense for the three months ended in Dec. 2024 was ₩-1,202 Mil. Its Operating Income for the three months ended in Dec. 2024 was ₩-33,462 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2024 was ₩22,663 Mil.

GemVax & KAEL Co's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

GemVax & KAEL Co did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

GemVax & KAEL Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Semiconductors » GemVax & KAEL Co Ltd (XKRX:082270) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

894, Tamnip-Dong, Yuseong-Gu, Daejeon, KOR, 305-510

Website

http://www.kael.co.kr

GemVax & KAEL Co Ltd is primarily engaged in manufacturing and commercializing of coating resin and filters for semiconductors and panel display production. It offers chemical air filter, scrubber resin, and devices for preventing environmental contamination and eliminating harmful gas, for semiconductor and display industry. Its other business operations include research and development of anti-cancer immunotherapeutic and peptide drugs. The company organizes its business operations into three distinct segments: Environmental Pollution Control Business, IT Business, Bio-business. The company's product portfolio consists fundamental products, semiconductor, and display, equipment and system, fire evacuation mask 5aver.

GemVax & KAEL Co Headlines

No Headlines